Insmed (INSM) EBIT Growth (1y) (2011 - 2026)
Insmed (INSM) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 38.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.21% |
| Dec 31, 2025 | -38.77% |
| Sep 30, 2025 | -71.49% |
| Jun 30, 2025 | -8.30% |
| Mar 31, 2025 | -70.54% |
| Dec 31, 2024 | -29.25% |
| Sep 30, 2024 | -44.53% |
| Jun 30, 2024 | -22.66% |
| Mar 31, 2024 | 1.79% |
| Dec 31, 2023 | -17.69% |
| Sep 30, 2023 | -15.64% |
| Jun 30, 2023 | -166.69% |
| Mar 31, 2023 | -64.93% |
| Dec 31, 2022 | -52.88% |
| Sep 30, 2022 | -23.24% |
| Jun 30, 2022 | 0.28% |
| Mar 31, 2022 | -7.16% |
| Dec 31, 2021 | -4.80% |
| Sep 30, 2021 | -84.30% |
| Jun 30, 2021 | -63.67% |